(2) CTCs derived from primary tumors or metastatic lesions can be detected in blood, providing the opportunity that assessment of the levels of PD-L1 expression in CTCs might recapitulate the PD-L1 expression pattens in tumor tissues [15]. The gene discussed is CD274; the disease is neoplasm.